HOUSTON, Dec. 3 /PRNewswire/ -- Three US Oncology, Inc. businesses received a Safety Excellence Perfect Record Award in the Occupational Safety & Health category from the National Safety Council. Since inception in 2005, US Oncology Specialty, LP; US Oncology Clinical & Research Pharmacy distribution center; and OncologyRx Care Advantage(TM) oral oncology pharmacy have continuously received the Occupational Excellence Award from the national organization, making this the third year the US Oncology businesses have been awarded. More information can be found at www.usoncology.com.
"We are very proud of our continuous safety record," says Rolando DeCardenas, vice president and general manager of the three US Oncology companies. "It is very difficult in the distribution business to go through a year of no accidents. To be able to achieve this continuously since inception, and for all three businesses, speaks volumes about the safety initiatives we have in place. The managers and leaders of the business units, our Compliance team, and the associates have done a great job of eliminating workplace accidents. We are very proud of this accomplishment."
The award is presented to companies, units and/or facilities that have completed a period of at least 12 consecutive months without incurring an occupational injury or illness that resulted in days away from work or death.
From 2008 to 2009, US Oncology Specialty, OncologyRx Care Advantage, and US Oncology Clinical & Research Pharmacy distribution center each achieved a zero percent incidence rate for number of days away from work. Following are the 2009 statistics for each:
Formed in 1999, US Oncology works with physicians, payers, and manufacturers to offer advanced cancer care to patients in America. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology Specialty, LP, is US Oncology's VAWD(TM) certified drug distribution center focused on delivering safe and effective oncology drugs to community-based practices. Its ePedigree technology tracks all products from manufacturer to the practice, and back again in case of returns.
OncologyRx Care Advantage, a national oral oncology pharmacy, provides patients with convenient home delivery of oral cancer therapies and the additional support necessary for safe and supervised use of these oral therapy treatments. Last year the specialty pharmacy successfully expanded to a national service offering, bringing access to home delivery of oral drugs and critical patient support to cancer patients in all 50 U.S. states and the territory of Puerto Rico.
US Oncology Clinical & Research Pharmacy distribution center distributes investigational drug products related to clinical research to oncology practices involved in US Oncology Research.
About US Oncology
US Oncology, Inc., headquartered in The Woodlands, Texas, works closely with physicians, payers, biotechnology, pharmaceutical and medical equipment manufacturers, to identify and deliver innovative services that enhance patient access to advanced cancer care. US Oncology supports one of the nation's foremost cancer treatment and research networks, accelerating the availability and use of evidence-based medicine and shared best practices.
US Oncology uses its expertise to support every aspect of the cancer care delivery system--from drug development to distribution and outcomes measurement--enabling the company to help increase the efficiency and safety of cancer care. According to the company's last quarterly earnings report, US Oncology is affiliated with 1,310 physicians operating in 493 locations, including 98 radiation oncology facilities in 39 states. For more information, visit the company's Web site, www.usoncology.com.
About the National Safety Council
The National Safety Council saves lives by preventing injuries and deaths at work, in homes and communities, and on the roads, through leadership, research, education and advocacy.
SOURCE US Oncology, Inc.
|SOURCE US Oncology, Inc.|
Copyright©2009 PR Newswire.
All rights reserved